DARPA is soliciting proposals for research supporting the potential use of Bdellovibrio and/or Micavibrio bacterial predators as therapeutics against infections caused by Gram-negative antibiotic-resistant and priority threat pathogens.
General information about this opportunity
Last Known Status
Deleted 01/08/2015 (Archived.)
Agency: Department of Defense
Office: ADVANCED RESEARCH PROJECTS AGENCY
Type(s) of Assistance Offered
Cooperative Agreement, Other, Procurement Contract
What is the process for applying and being award this assistance?
Other Assistance Considerations
Formula and Matching Requirements
This program does not have cost sharing or matching requirements.
Who do I contact about this opportunity?